Over-50s happy to pay

More than half of over-50s would pay for drugs or treatments not available on the NHS, according to a survey for Saga.

The poll of 6,000 people aged over 50 found that 52 per cent would pay for treatment for conditions like cancer if they were not available on the NHS because NICE had ruled they were not cost-effective.

A tenth of respondents said they would pay over £5,200 a year for treatments.

The researchers found that 45 per cent would pay for preventive drugs costing an average of £670 a year. The survey found that 81 per cent would take a daily pill to prevent future disease.

A total of 15 per cent of respondents said that they had been denied NHS treatment on the basis of cost.

Under the present healthcare system, if someone decides to pay for an element of their own treatment they have to fund all their treatment privately.

However, it is likely that the new generation of treatments will cost more than £670 a year, according to Saga.

www.saga.co.uk

Self-funding

52% of over-50s would fund care

Source: Saga.

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...